Unofficial Guide to South By Southwest 2015 has ended
Unfortunately, we won’t be offering a 2016 guide. Please use Do512 + Official SXSW

11,217 official + unofficial events during SXSW
(last updated March 23, 2015). Our goal is to be the most complete guide. Anything missing?
Official details at sxsw.com. South by Southwest, SXSW, and related marks and logos are trademarks of SXSW, LLC., used with permission. Follow @sched + @SouthByFreeNOMS

avatar for Phyllis Whiteley

Phyllis Whiteley

Mohr Davidow Ventures
Venture Partner
Phyllis Whiteley is a Venture Partner with Mohr Davidow Ventures. Dr. Whiteley has built a career founded on her passion for personalized medicine, global healthcare, and transformative life science innovations. Dr. Whiteley brings more than 25 years of international experience across academia, Biotech, and Pharma in R&D, business, and portfolio management and has held numerous executive positions including CEO and Board of Directors. At Mohr Davidow Ventures, Dr. Whiteley provides hands-on leadership in building and creating companies in diagnostics, life science tools, and personalized medicine including Verinata Health, acquired by Illumina (NASDAQ: ILMN). Her expertise includes strategic planning, financing, partnerships, restructuring, building executive teams, and M&A. Dr. Whiteley previously co-founded Anaphore, Inc. (now RuiYi) with 5AM Ventures. Prior to her work in venture, she was an Officer and Senior VP, Business Development, Licensing, and Alliance Management at Perlegen Sciences, Inc. Before joining Perlegen, she served as VP, Strategic Portfolio Management for Roche. During her ten years with Roche she held various positions in Business Development based in Basel, Switzerland and R&D leadership positions in the US. Her work resulted in multiple new chemical entities and publications. Prior to her Roche tenure, Dr. Whiteley was a Senior Research Immunologist with Merck.